SpeechPathology.comPhone: 800-242-5183

Host Healthcare Careers
 

Speech Therapy for Patients with Myasthenia Gravis

Patrick Coppens, Ph.D

October 8, 2007


Question

What should be the main focus of speech and language therapy for patients with myasthenia gravis?

Answer

Individuals with myasthenia gravis have a disorder at the level of the neuromuscular junction, where the acetylcholine neurotransmitter is unable to sustain its activity on the receptors in the muscles. Consequently, patients are able to perform all movements for a while, but are unable to sustain the activity for an extended period of time. Essentially, muscles fatigue.

Individuals with myasthenia gravis have motor speech difficulties, specifically flaccid dysarthria, but no language disorders. With use, articulation becomes increasingly imprecise, hypernasality increases, etc. The assessment should include stress testing to show decrease of articulatory precision with use.

These patients are usually on anticholinesterase medications which help significantly. In most cases, speech pathologists focus on environmental modifications and AAC. The patient is asked to take multiple periods of rest and to avoid prolonged use of the articulatory musculature. Also, the SLP assesses and recommends an appropriate AAC device tailored to the patient's needs and preferences. This allows the patient to keep communicating during periods of rest or when speech becomes unintelligible. Because of intact language and cognition, a high tech AAC device is usually appropriate.

Patrick Coppens, Ph.D. is Professor and Chair of Communication Disorders and Sciences and Neurogenics Instructor at Plattsburgh State University of New York.

Related Courses

Visual Supports and Dementia: Facilitating Interaction and Participation [Video Course]

Presenter

Kristin Whitfield, MA, CCC-SLP
Course: #7063
CEUs/Hours Offered: ASHA/0.1 Intermediate, Professional; Kansas DHE, LTS-S1370/1.0; SAC/1.0
This course is included in $99 CEU Total Access, Learn More
Course Details

This Course is included in CEU Total Access.

Only $99/yr

Buy Now

Clinical Uses of the Cognitive Linguistic Quick Test [Video Course]

Presenter

Nancy Helm-Estabrooks, Sc.D, CCC-SLP
Course: #3991
CEUs/Hours Offered: ASHA/0.1; Kansas DHE, LTS-S1370/1.0; SAC/1.0
This course is included in $99 CEU Total Access, Learn More
Course Details

This Course is included in CEU Total Access.

Only $99/yr

Buy Now

Acquired Apraxia of Speech: Current views on diagnosis and treatment [Video Course]

Presenter

Edwin Maas, Ph.D.
Course: #5168
CEUs/Hours Offered: ASHA/0.1 Intermediate, Professional; Kansas DHE, LTS-S1370/1.0; SAC/1.0
This course is included in $99 CEU Total Access, Learn More
Course Details

This Course is included in CEU Total Access.

Only $99/yr

Buy Now

Evaluation and Assessment of Cognitive-Communication Disorders in Individuals with Traumatic Brain Injury [Video Course]

Presenter

Victoria Harding, M.S., M.B.A., CCC-SLP
Course: #5180
CEUs/Hours Offered: ASHA/0.1 Intermediate, Professional; Kansas DHE, LTS-S1370/1.0; SAC/1.0
This course is included in $99 CEU Total Access, Learn More
Course Details

This Course is included in CEU Total Access.

Only $99/yr

Buy Now

Assistive Technology for Individuals with Traumatic Brain Injury: Current technologies and available evidence [Video Course]

Presenters

Jennifer Ostergren, PhD, CCC-SLPMegan Elizabeth Carey, B.A.Jerica O. Montgomery, B.A.
Course: #5197
CEUs/Hours Offered: ASHA/0.1 Intermediate, Professional; Kansas DHE, LTS-S1370/1.0; SAC/1.0
This course is included in $99 CEU Total Access, Learn More
Course Details

This Course is included in CEU Total Access.

Only $99/yr

Buy Now